Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFNλ) in cutaneous lupus erythematosus (Q84764433)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20720564%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

title

Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFNλ) in cutaneous lupus erythematosus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20720564%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

cutaneous lupus erythematosus

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20720564%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

3

Beate M Kümmerer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20720564%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

Sabine Zahn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20720564%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Claudia Rehkämper

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20720564%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Sandra Ferring-Schmidt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20720564%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Thomas Bieber

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20720564%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Thomas Tüting

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20720564%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

language of work or name

English

0 references

publication date

19 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20720564%20AND%20SRC:MED&resulttype=core&format=json

Journal of Investigative Dermatology

10 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20720564%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

volume

131

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20720564%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20720564%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

133-140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20720564%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/jid.2010.244

10 February 2020

exact match

0 references

cites work

An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

Type I interferon correlates with serological and clinical manifestations of SLE

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

Pathogenesis of cutaneous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

Interferons and autoimmune disorders

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

Systemic lupus erythematosus and the type I interferon system

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

The type I interferon system in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

The innate immune system in SLE: type I interferons and dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

IL-28, IL-29 and their class II cytokine receptor IL-28R

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

Lichenoid tissue reaction/interface dermatitis: clinical and histological perspectives

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

Role of the chemokine receptor CCR4 and its ligand thymus- and activation-regulated chemokine/CCL17 for lymphocyte recruitment in cutaneous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in "interface dermatitis".

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021

Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.244

7 January 2021